Clinical trials
Completed HIV Seropositivity trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 5 |
| 2023 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 44 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Washington | 4 |
| Centers for Disease Control and Prevention | 2 |
| Emory University | 2 |
| Immunobiology Research Institute | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| University of California, San Diego | 2 |
| University of North Carolina, Chapel Hill | 2 |
| Absolute Return for Kids | 1 |
| Aga Khan University | 1 |
| Azienda Policlinico Umberto I | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| HIV Seropositivity | 44 |
| HIV Infections | 12 |
| Acquired Immunodeficiency Syndrome | 8 |
| AIDS-Related Complex | 2 |
| Diarrhea | 2 |
| Poliomyelitis | 2 |
| Sexually Transmitted Diseases | 2 |
| AIDS-Related Opportunistic Infections | 1 |
| Liver Diseases | 1 |
| Opioid-Related Disorders | 1 |
Trials
Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.